Yuchen Han (Yedan Chen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Small Cell Lung Cancer

Top Venues

NPJ precision oncology

Cancer immunology, immunotherapy : CII

Nature communications

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shengnan Chen, Tao Hu, Jikai Zhao, Qian Zhu, Jin Wang, Zhan Huang, Chan Xiang, Ruiying Zhao, Changbin Zhu, Shun Lu, Yuchen Han
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance. NPJ precision oncology 8 (1) (2024)
Shengnan Chen, Tao Hu, Jikai Zhao, Qian Zhu, Jin Wang, Zhan Huang, Chan Xiang, Ruiying Zhao, Changbin Zhu, Shun Lu, Yuchen Han
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance. NPJ precision oncology 8 (1) (2024)
Shengnan Chen, Tao Hu, Jikai Zhao, Qian Zhu, Jin Wang, Zhan Huang, Chan Xiang, Ruiying Zhao, Changbin Zhu, Shun Lu, Yuchen Han
Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance. NPJ precision oncology 8 (1) (2024)
Ruiying Zhao, Yunhua Xu, Yuchen Han, Jiajun Zhang, Fei Teng, Sha Liao, Shengnan Chen, Qian Wu, Chan Xiang, Jiaohui Pang, Zhanxian Shang, Jikai Zhao, Hairong Bao, Hua Bao, Yang Shao, Shun Lu, Yuchen Han
Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma. NPJ precision oncology 7 (1) (2023)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Ming Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial. Clinical and translational medicine 12 (4) (2022)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial. Cancer immunology, immunotherapy : CII (2022)
Si-Yang Liu, Hua Bao, Qun Wang, Wei-Min Mao, Yuchen Han, Xiaoling Tong, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Hong-Hong Yan, Song Dong, Xu Chao Zhang, Jian Su, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Xue Wu, Yang W Shao, Wen-Zhao Zhong, Yi-Long Wu
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes. Nature communications 12 (1) (2021)